Overcoming mitomycin C resistance with semisynthetic derivatives
Brattain, M.G.; Willson, J.K.; Long, B.H.; Chakrabarty, S.; Yeoman, L.C.; Stringfellow, D.A.
Progress in Clinical and Biological Research 223: 63-79
1986
ISSN/ISBN: 0361-7742 PMID: 3101070 Document Number: 280592
Document emailed within 1 workday
Related Documents
Povarov, L.S. 1977: Antitumor antibiotics of the anthracycline series and their semisynthetic derivatives Antibiotiki 22(7): 653-667Mercier, C. 1982: Peptide alkaloids of spurred rye and their semisynthetic derivatives. III. Ergot in therapeutics Journal de Pharmacie de Belgique 37(4): 289-298
Knibbe, H. 1992: Overcoming resistance. Mind your back Nursing Times 88(52): 46-47
Takeda, K. 2009: Overcoming resistance to EGFR-TKi in lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(4): 552-556
Saijo, N.; Nishio, K.; Yoshida, M. 1998: Overcoming drug resistance in lung cancer Oncology 12(1 Suppl 2: 87-89
Lyshak, F.; Bassin, D.; Robbins, A. 1981: The creative act as a means of overcoming resistance in treatment Psychoanalytic Review 68(3): 395-407
McIntosh, E.; David, G. 2007: New antibiotics, efflux pumps and overcoming resistance Casopis Lekaru Ceskych 146(2): 102-106; Discussion: 107-108
Grishin, M.N.; Svistov, V.V.; Krivoshein, I.S. 2002: Ways of overcoming drug resistance in patients with pulmonary tuberculosis Problemy Tuberkuleza 3: 16-18
Borowski, E.; Bontemps-Gracz, M.M.; Piwkowska, A. 2005: Strategies for overcoming ABC-transporters-mediated multidrug resistance (MDR) of tumor cells Acta Biochimica Polonica 52(3): 609-627
Kibrik, B.S.; Pavlov, A.V.; Zakharov, A.V.; Kreĭtsberg, G.N. 2011: Overcoming resistance of tuberculosis infectious agent by isoniazid-silver nanocomposite Eksperimental'naia i Klinicheskaia Farmakologiia 74(4): 24-26
Yoshida, T.; Shimizu, K.; Ushio, Y.; Hayakawa, T.; Mogami, H.; Sakamoto, Y. 1986: Overcoming of ACNU resistance in a subline of rat glioma in vitro and in vivo by reserpine Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(6): 2141-2146
Hirose, M.; Takeda, E.; Kuroda, Y. 1993: Overcoming of vincristine resistance in HL-60 human promyelocytic leukemia cell line by dipyridamole Tokushima Journal of Experimental Medicine 40(1-2): 27-33
Severin, E.S.; Posypanova, G.A. 2011: Molecular physiology of receptor mediated endocytosis and its role in overcoming multidrug resistance Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 97(6): 553-565
Xu, B.; Sun, Y.; Singh, S.V. 1995: Mechanism of resistance to mitomycin C in a human bladder cancer cell line Zhonghua Zhong Liu Za Zhi 17(5): 343-346
Stefanková, Z.; Barancík, M.; Breier, A. 1996: Overcoming of P-glycoprotein mediated vincristine resistance of L1210/VCR mouse leukemic cells could be induced by pentoxifyline but not by theophylline and caffeine Neoplasma 43(1): 11-15
Zhu, H.-B.; Huang, X.-F.; Hu, J.-Z.; Zhou, W.; Chen, W.; Chen, L.-L.; He, C. 2008: Overcoming acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand by Bcl-XL small interfering RNA in human colon cancer Zhonghua Zhong Liu Za Zhi 30(4): 245-249
Tsuruo, T.; Iida, H.; Tsukagoshi, S.; Sakurai, Y. 1981: Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil Cancer Research 41(5): 1967-1972
Gupta, V.P.; Saxena, T. 2003: Comparison of single-drop mitomycin C regime with other mitomycin C regimes in pterygium surgery Indian Journal of Ophthalmology 51(1): 59-65
Hashida, M.; Kato, A.; Takakura, Y.; Sezaki, H. 1984: Disposition and pharmacokinetics of a polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate, in the rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 12(4): 492-499
Siegel, D.; Gibson, N.W.; Preusch, P.C.; Ross, D. 1990: Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells Cancer Research 50(23): 7483-7489